Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xiongdan Chuanbei Pipa Gao is a Traditional Chinese Medicine (TCM) syrup developed and manufactured by Jiangxi Yaodu Renhe Pharmaceutical. It is primarily indicated for the treatment of acute bronchitis and acute tracheobronchitis, particularly when symptoms include cough with thick yellow phlegm, dry throat, and chest discomfort. The formulation leverages the synergistic effects of bear gall powder (Xiongdan), which provides heat-clearing and detoxifying properties, alongside Bulbus Fritillariae Cirrhosae (Chuanbei) and loquat leaf (Pipaye) to resolve phlegm and suppress cough. Pharmacologically, the preparation exhibits antitussive, expectorant, and anti-inflammatory activities, helping to clear respiratory secretions and soothe the airway.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on xiongdan chuanbei pipa gao.